Shi Yuankai, MD, PhD, is a Professor of Tenure Track at Peking Union Medical College, Chinese Academy of Medical Sciences, and a Chief Physician specializing in Medical Oncology. He is also a Doctoral Supervisor in Oncology. Professor Shi currently serves as President of the China Cancer Foundation, Deputy Director of the National Drug Clinical Trial Institution at National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, President of the Oncology Physicians Branch of the Chinese Medical Doctor Association, Chair of the Lymphoma Professional Committee of the Chinese Anti-Cancer Association, Member of the Drug Evaluation Expert Advisory Committee of the National Medical Products Administration, and Deputy Editor-in-Chief of the Chinese Medical Journal. He has led more than 40 national research projects and conducted over 350 clinical studies. He has published more than 400 articles as the first author and/or corresponding author, and has edited or translated more than 20 academic books. He has led the development of more than 20 clinical practice guidelines, diagnostic and treatment standards, and expert consensus statements. Professor Shi has received numerous honors and awards, including the First Prize and Second Prize of the National Science and Technology Progress Award, nine provincial and ministerial-level scientific research achievement awards, seven research achievement awards from national academic organizations, and eight national invention patents. He is also a recipient of the First National Innovation and Entrepreneurship Medal, the National Outstanding Science and Technology Worker Award, and the Chinese Physician Award, and has been granted the State Council Special Allowance.